This selection from the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Thyroid Carcinoma focuses on anaplastic carcinoma because substantial changes were made to the systemic therapy recommendations for the 2015 update. Dosages and frequency of administration are now provided, docetaxel/doxorubicin regimens were added, and single-agent cisplatin was deleted because it is not recommended for patients with advanced or metastatic anaplastic thyroid cancer.

  • 1.

    HowladerNNooneAKrapchoM. SEER Cancer Statistics Review 1975-2012 based on November 2014 SEER data submission posted to the SEER web site April 2015. Bethesda, MD: National Cancer Institute; 2015. Available at: http://seer.cancer.gov/csr/1975_2012/.

    • Search Google Scholar
    • Export Citation
  • 2.

    EdgeSBByrdDRComptonCC. AJCC Cancer Staging Manual7th ed.New York: Springer; 2010:1646.

  • 3.

    MazzaferriEL. Thyroid carcinoma: papillary and follicular. In: MazzaferriELSamaanN eds. Endocrine Tumors. Cambridge: Blackwell Scientific Publications1993:278333.

    • Search Google Scholar
    • Export Citation
  • 4.

    HegedusL. Clinical practice: the thyroid nodule. N Engl J Med2004;351:17641771.

  • 5.

    CooperDSDohertyGMHaugenBR. Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid2009;19:11671214.

    • Search Google Scholar
    • Export Citation
  • 6.

    EzzatSSartiDACainDRBraunsteinGD. Thyroid incidentalomas: prevalence by palpation and ultrasonography. Arch Intern Med1994;154:18381840.

    • Search Google Scholar
    • Export Citation
  • 7.

    RonELubinJHShoreRE. Thyroid cancer after exposure to external radiation: a pooled analysis of seven studies. Radiat Res1995;141:259277.

    • Search Google Scholar
    • Export Citation
  • 8.

    SchneiderABBekermanCLelandJ. Thyroid nodules in the follow-up of irradiated individuals: comparison of thyroid ultrasound with scanning and palpation. J Clin Endocrinol Metab1997;82:40204027.

    • Search Google Scholar
    • Export Citation
  • 9.

    SiegelRLMillerKDJemalA. Cancer statistics, 2015. CA Cancer J Clin2015;65:529.

  • 10.

    JonklaasJNogueras-GonzalezGMunsellM. The impact of age and gender on papillary thyroid cancer survival. J Clin Endocrinol Metab2012;97:E878887.

    • Search Google Scholar
    • Export Citation
  • 11.

    StroupAMHarrellCJHergetKA. Long-term survival in young women: hazards and competing risks after thyroid cancer. J Cancer Epidemiol2012;2012:641372.

    • Search Google Scholar
    • Export Citation
  • 12.

    AltekruseSKosaryCKrapchoM. SEER Cancer Statistics Review 1975–2007. Bethesda, MD: National Cancer Institute; 2010.

  • 13.

    SEER Cancer Statistics Review 1975–2006. Bethesda, MD: National Cancer Institute; 2009.

  • 14.

    MazzaferriELJhiangSM. Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer. Am J Med1994;97:418428.

    • Search Google Scholar
    • Export Citation
  • 15.

    DaviesLWelchHG. Increasing incidence of thyroid cancer in the United States, 1973–2002. JAMA2006;295:21642167.

  • 16.

    DaviesLWelchHG. Current thyroid cancer trends in the United States. JAMA Otolaryngol Head Neck Surg2014;140:317322.

  • 17.

    SiegelRMaJZouZJemalA. Cancer statistics, 2014. CA Cancer J Clin2014;64:929.

  • 18.

    LiNDuXLReitzelLR. Impact of enhanced detection on the increase in thyroid cancer incidence in the United States: review of incidence trends by socioeconomic status within the surveillance, epidemiology, and end results registry, 1980-2008. Thyroid2013;23:103110.

    • Search Google Scholar
    • Export Citation
  • 19.

    WilhelmS. Evaluation of thyroid incidentaloma. Surg Clin North Am2014;94:485497.

  • 20.

    ItoYTomodaCUrunoT. Papillary microcarcinoma of the thyroid: how should it be treated?World J Surg2004;28:11151121.

  • 21.

    Aschebrook-KilfoyBGroganRHWardMH. Follicular thyroid cancer incidence patterns in the United States, 1980–2009. Thyroid2013;23:10151021.

    • Search Google Scholar
    • Export Citation
  • 22.

    Aschebrook-KilfoyBWardMHSabraMMDevesaSS. Thyroid cancer incidence patterns in the United States by histologic type, 1992–2006. Thyroid2011;21:125134.

    • Search Google Scholar
    • Export Citation
  • 23.

    YuGPLiJCBranovanD. Thyroid cancer incidence and survival in the national cancer institute surveillance, epidemiology, and end results race/ethnicity groups. Thyroid2010;20:465473.

    • Search Google Scholar
    • Export Citation
  • 24.

    ChenAYJemalAWardEM. Increasing incidence of differentiated thyroid cancer in the United States, 1988–2005. Cancer2009;115:38013807.

    • Search Google Scholar
    • Export Citation
  • 25.

    EnewoldLZhuKRonE. Rising thyroid cancer incidence in the United States by demographic and tumor characteristics, 1980–2005. Cancer Epidemiol Biomarkers Prev2009;18:784791.

    • Search Google Scholar
    • Export Citation
  • 26.

    SiegelRWardEBrawleyOJemalA. Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J Clin2011;61:212236.

    • Search Google Scholar
    • Export Citation
  • 27.

    JemalASiegelRWardE. Cancer statistics, 2009. CA Cancer J Clin2009;59:225249.

  • 28.

    AreCShahaAR. Anaplastic thyroid carcinoma: biology, pathogenesis, prognostic factors, and treatment approaches. Ann Surg Oncol2006;13:453464.

    • Search Google Scholar
    • Export Citation
  • 29.

    KebebewEGreenspanFSClarkOH. Anaplastic thyroid carcinoma: treatment outcome and prognostic factors. Cancer2005;103:13301335.

  • 30.

    GillilandFDHuntWCMorrisDMKeyCR. Prognostic factors for thyroid carcinoma: a population-based study of 15,698 cases from the Surveillance, Epidemiology and End Results (SEER) program 1973–1991. Cancer1997;79:564573.

    • Search Google Scholar
    • Export Citation
  • 31.

    SmallridgeRCAinKBAsaSL. American Thyroid Association guidelines for management of patients with anaplastic thyroid cancer. Thyroid2012;22:11041139.

    • Search Google Scholar
    • Export Citation
  • 32.

    MorettiFFarsettiASodduS. p53 re-expression inhibits proliferation and restores differentiation of human thyroid anaplastic carcinoma cells. Oncogene1997;14:729740.

    • Search Google Scholar
    • Export Citation
  • 33.

    MaatoukJBarklowTAZakariaWAl-AbbadiMA. Anaplastic thyroid carcinoma arising in long-standing multinodular goiter following radioactive iodine therapy: report of a case diagnosed by fine needle aspiration. Acta Cytol2009;53:581583.

    • Search Google Scholar
    • Export Citation
  • 34.

    AldingerKASamaanNAIbanezMHillCSJr.Anaplastic carcinoma of the thyroid: a review of 84 cases of spindle and giant cell carcinoma of the thyroid. Cancer1978;41:22672275.

    • Search Google Scholar
    • Export Citation
  • 35.

    KeutgenXMSadowskiSMKebebewE. Management of anaplastic thyroid cancer. Gland Surg2015;4:4451.

  • 36.

    ThompsonLDWienekeJAPaalE. A clinicopathologic study of minimally invasive follicular carcinoma of the thyroid gland with a review of the English literature. Cancer2001;91:505524.

    • Search Google Scholar
    • Export Citation
  • 37.

    ShermanSI. Anaplastic carcinoma: Clinical aspects. In: WartofskyLVan NostrandD eds. Thyroid Cancer: A Comprehensive Guide to Clinical Management2nd ed.Totowa, NJ: Humana Press; 2006:629632.

    • Search Google Scholar
    • Export Citation
  • 38.

    LayfieldLJCibasESGharibHMandelSJ. Thyroid aspiration cytology: current status. CA Cancer J Clin2009;59:99110.

  • 39.

    BalochZWCibasESClarkDP. The National Cancer Institute Thyroid Fine Needle Aspiration State of the Science Conference: a summation. Cytojournal2008;5:6.

    • Search Google Scholar
    • Export Citation
  • 40.

    EilersSGLaPolicePMukunyadziP. Thyroid fine-needle aspiration cytology: performance data of neoplastic and malignant cases as identified from 1558 responses in the ASCP Non-GYN Assessment program thyroid fine-needle performance data. Cancer Cytopathol2014;122:745750.

    • Search Google Scholar
    • Export Citation
  • 41.

    YehMWDemircanOItuartePClarkOH. False-negative fine-needle aspiration cytology results delay treatment and adversely affect outcome in patients with thyroid carcinoma. Thyroid2004;14:207215.

    • Search Google Scholar
    • Export Citation
  • 42.

    AsaSLBedardYC. Fine-needle aspiration cytology and histopathology. In: ClarkOHNoguchiS eds. Thyroid Cancer: Diagnosis and Treatment. St Louis: Quality Medical Publishing; 2000:105126.

    • Search Google Scholar
    • Export Citation
  • 43.

    SeethalaRRAsaSLCartySE. Protocol for the examination of specimens from patients with carcinomas of the thyroid gland: based on AJCC/UICC TNM7th edition: Protocol web posting date: August 2014: College of American Pathologists; 2014. Available at: http://www.cap.org/web/home/resources/cancer-reporting-tools/cancer-protocol-templates.

    • Search Google Scholar
    • Export Citation
  • 44.

    TakashimaSMorimotoSIkezoeJ. CT evaluation of anaplastic thyroid carcinoma. AJR Am J Roentgenol1990;154:10791085.

  • 45.

    NeffRLFarrarWBKloosRTBurmanKD. Anaplastic thyroid cancer. Endocrinol Metab Clin North Am2008;37:525538xi.

  • 46.

    WeinROWeberRS. Anaplastic thyroid carcinoma: palliation or treatment?Curr Opin Otolaryngol Head Neck Surg2011;19:113118.

  • 47.

    UntchBROlsonJAJr.Anaplastic thyroid carcinoma, thyroid lymphoma, and metastasis to thyroid. Surg Oncol Clin N Am2006;15:661679x.

  • 48.

    ShahaAR. Airway management in anaplastic thyroid carcinoma. Laryngoscope2008;118:11951198.

  • 49.

    VenkateshYSOrdonezNGSchultzPN. Anaplastic carcinoma of the thyroid: a clinicopathologic study of 121 cases. Cancer1990;66:321330.

  • 50.

    SugitaniIMiyauchiASuginoK. Prognostic factors and treatment outcomes for anaplastic thyroid carcinoma: ATC Research Consortium of Japan cohort study of 677 patients. World J Surg2012;36:12471254.

    • Search Google Scholar
    • Export Citation
  • 51.

    AkaishiJSuginoKKitagawaW. Prognostic factors and treatment outcomes of 100 cases of anaplastic thyroid carcinoma. Thyroid2011;21:11831189.

    • Search Google Scholar
    • Export Citation
  • 52.

    JunorEJPaulJReedNS. Anaplastic thyroid carcinoma: 91 patients treated by surgery and radiotherapy. Eur J Surg Oncol1992;18:8388.

  • 53.

    McIverBHayIDGiuffridaDF. Anaplastic thyroid carcinoma: a 50-year experience at a single institution. Surgery2001;130:10281034.

  • 54.

    BurgeMRZeiseTMJohnsenMW. Risks of complication following thyroidectomy. J Gen Intern Med1998;13:2431.

  • 55.

    UdelsmanRLakatosELadensonP. Optimal surgery for papillary thyroid carcinoma. World J Surg1996;20:8893.

  • 56.

    PattouFCombemaleFFabreS. Hypocalcemia following thyroid surgery: incidence and prediction of outcome. World J Surg1998;22:718724.

  • 57.

    HassanainMWexlerM. Conservative management of well-differentiated thyroid cancer. Can J Surg2010;53:109118.

  • 58.

    SosaJABowmanHMTielschJM. The importance of surgeon experience for clinical and economic outcomes from thyroidectomy. Ann Surg1998;228:320330.

    • Search Google Scholar
    • Export Citation
  • 59.

    DumkeAKPelzTVordermarkD. Long-term results of radiotherapy in anaplastic thyroid cancer. Radiat Oncol2014;9:90.

  • 60.

    BrierleyJShermanE. The role of external beam radiation and targeted therapy in thyroid cancer. Semin Radiat Oncol2012;22:254262.

  • 61.

    BurnisonCMLimS. Multimodal approach to anaplastic thyroid cancer. Oncology (Williston Park)2012;26:378384390.

  • 62.

    WangYTsangRAsaS. Clinical outcome of anaplastic thyroid carcinoma treated with radiotherapy of once- and twice-daily fractionation regimens. Cancer2006;107:17861792.

    • Search Google Scholar
    • Export Citation
  • 63.

    ChiuACDelpassandESShermanSI. Prognosis and treatment of brain metastases in thyroid carcinoma. J Clin Endocrinol Metab1997;82:36373642.

    • Search Google Scholar
    • Export Citation
  • 64.

    De CrevoisierRBaudinEBachelotA. Combined treatment of anaplastic thyroid carcinoma with surgery, chemotherapy, and hyperfractionated accelerated external radiotherapy. Int J Radiat Oncol Biol Phys2004;60:11371143.

    • Search Google Scholar
    • Export Citation
  • 65.

    KimJHLeeperRD. Treatment of locally advanced thyroid carcinoma with combination doxorubicin and radiation therapy. Cancer1987;60:23722375.

    • Search Google Scholar
    • Export Citation
  • 66.

    MohebatiADilorenzoMPalmerF. Anaplastic thyroid carcinoma: a 25-year single-institution experience. Ann Surg Oncol2014;21:16651670.

  • 67.

    DerbelOLimemSSegura-FerlayC. Results of combined treatment of anaplastic thyroid carcinoma (ATC). BMC Cancer2011;11:469.

  • 68.

    WallinGLundellGTennvallJ. Anaplastic giant cell thyroid carcinoma. Scand J Surg2004;93:272277.

  • 69.

    SmallridgeRC. Approach to the patient with anaplastic thyroid carcinoma. J Clin Endocrinol Metab2012;97:25662572.

  • 70.

    BhatiaARaoAAngKK. Anaplastic thyroid cancer: Clinical outcomes with conformal radiotherapy. Head Neck2010;32:829836.

  • 71.

    SunXSSunSRGuevaraN. Chemoradiation in anaplastic thyroid carcinomas. Crit Rev Oncol Hematol2013;86:290301.

  • 72.

    GregoireVMackieTR. State of the art on dose prescription, reporting and recording in Intensity-Modulated Radiation Therapy (ICRU report No. 83). Cancer Radiother2011;15:555559.

    • Search Google Scholar
    • Export Citation
  • 73.

    Prescribing, Recording, and Reporting Photon-Beam Intensity-Modulated Radiation Therapy (IMRT): Contents. J ICRU2010;10:NP.

  • 74.

    SosaJABalkissoonJLuSP. Thyroidectomy followed by fosbretabulin (CA4P) combination regimen appears to suggest improvement in patient survival in anaplastic thyroid cancer. Surgery2012;152:10781087.

    • Search Google Scholar
    • Export Citation
  • 75.

    Swaak-KragtenATde WiltJHSchmitzPI. Multimodality treatment for anaplastic thyroid carcinoma--treatment outcome in 75 patients. Radiother Oncol2009;92:100104.

    • Search Google Scholar
    • Export Citation
  • 76.

    LoweNMLoughranSSlevinNJYapBK. Anaplastic thyroid cancer: the addition of systemic chemotherapy to radiotherapy led to an observed improvement in survival: a single centre experience and review of the literature. Scientific World J2014;2014:674583.

    • Search Google Scholar
    • Export Citation
  • 77.

    HigashiyamaTItoYHirokawaM. Induction chemotherapy with weekly paclitaxel administration for anaplastic thyroid carcinoma. Thyroid2010;20:714.

    • Search Google Scholar
    • Export Citation
  • 78.

    AinKB. Anaplastic thyroid carcinoma: behavior, biology, and therapeutic approaches. Thyroid1998;8:715726.

  • 79.

    AinKBEgorinMJDeSimonePA. Treatment of anaplastic thyroid carcinoma with paclitaxel: phase 2 trial using ninety-six-hour infusion. Collaborative Anaplastic Thyroid Cancer Health Intervention Trials (CATCHIT) Group. Thyroid2000;10:587594.

    • Search Google Scholar
    • Export Citation
  • 80.

    BibleKCSumanVJMenefeeME. A multiinstitutional phase 2 trial of pazopanib monotherapy in advanced anaplastic thyroid cancer. J Clin Endocrinol Metab2012;97:31793184.

    • Search Google Scholar
    • Export Citation
  • 81.

    HaHTLeeJSUrbaS. A phase II study of imatinib in patients with advanced anaplastic thyroid cancer. Thyroid2010;20:975980.

  • 82.

    SavvidesPNagaiahGLavertuP. Phase II trial of sorafenib in patients with advanced anaplastic carcinoma of the thyroid. Thyroid2013;23:600604.

    • Search Google Scholar
    • Export Citation
  • 83.

    KeefeSMTroxelABRheeS. Phase II trial of sorafenib in patients with advanced thyroid cancer [abstract]. J Clin Oncol2011;29(Suppl 15):Abstract 5562.

    • Search Google Scholar
    • Export Citation
  • 84.

    BroseMSNuttingCMShermanSI. Rationale and design of decision: a double-blind, randomized, placebo-controlled phase III trial evaluating the efficacy and safety of sorafenib in patients with locally advanced or metastatic radioactive iodine (RAI)-refractory, differentiated thyroid cancer. BMC Cancer2011;11:349.

    • Search Google Scholar
    • Export Citation
  • 85.

    AntonelliAFallahiPUlisseS. New targeted therapies for anaplastic thyroid cancer. Anticancer Agents Med Chem2012;12:8793.

  • 86.

    PerriFLorenzoGDScarpatiGDBuonerbaC. Anaplastic thyroid carcinoma: a comprehensive review of current and future therapeutic options. World J Clin Oncol2011;2:150157.

    • Search Google Scholar
    • Export Citation
  • 87.

    DeshpandeHAGettingerSNSosaJA. Novel chemotherapy options for advanced thyroid tumors: small molecules offer great hope. Curr Opin Oncol2008;20:1924.

    • Search Google Scholar
    • Export Citation
  • 88.

    MooneyCJNagaiahGFuP. A phase II trial of fosbretabulin in advanced anaplastic thyroid carcinoma and correlation of baseline serum-soluble intracellular adhesion molecule-1 with outcome. Thyroid2009;19:233240.

    • Search Google Scholar
    • Export Citation
  • 89.

    SmallridgeRCMarlowLACoplandJA. Anaplastic thyroid cancer: molecular pathogenesis and emerging therapies. Endocr Relat Cancer2009;16:1744.

    • Search Google Scholar
    • Export Citation
  • 90.

    SosaJAEliseiRJarzabB. Randomized safety and efficacy study of fosbretabulin with paclitaxel/carboplatin against anaplastic thyroid carcinoma. Thyroid2014;24:232240.

    • Search Google Scholar
    • Export Citation
  • 91.

    FooteRLMolinaJRKasperbauerJL. Enhanced survival in locoregionally confined anaplastic thyroid carcinoma: a single-institution experience using aggressive multimodal therapy. Thyroid2011;21:2530.

    • Search Google Scholar
    • Export Citation
  • 92.

    NagaiahGHossainAMooneyCJ. Anaplastic thyroid cancer: a review of epidemiology, pathogenesis, and treatment. J Oncol2011;2011:542358.

  • 93.

    SiironenPHagstromJMaenpaaHO. Anaplastic and poorly differentiated thyroid carcinoma: therapeutic strategies and treatment outcome of 52 consecutive patients. Oncology2010;79:400408.

    • Search Google Scholar
    • Export Citation
  • 94.

    BrignardelloEGalloMBaldiI. Anaplastic thyroid carcinoma: clinical outcome of 30 consecutive patients referred to a single institution in the past 5 years. Eur J Endocrinol2007;156:425430.

    • Search Google Scholar
    • Export Citation
  • 95.

    YauTLoCYEpsteinRJ. Treatment outcomes in anaplastic thyroid carcinoma: survival improvement in young patients with localized disease treated by combination of surgery and radiotherapy. Ann Surg Oncol2008;15:25002505.

    • Search Google Scholar
    • Export Citation
  • 96.

    HeronDEKarimpourSGrigsbyPW. Anaplastic thyroid carcinoma: comparison of conventional radiotherapy and hyperfractionation chemoradiotherapy in two groups. Am J Clin Oncol2002;25:442446.

    • Search Google Scholar
    • Export Citation
  • 97.

    ChouAFraserSToonCW. A detailed clinicopathologic study of ALK-translocated papillary thyroid carcinoma. Am J Surg Pathol2015;39:652659.

    • Search Google Scholar
    • Export Citation
  • 98.

    ParkGKimTHLeeHO. Standard immunohistochemistry efficiently screens for anaplastic lymphoma kinase rearrangements in differentiated thyroid cancer. Endocr Relat Cancer2015;22:5563.

    • Search Google Scholar
    • Export Citation
  • 99.

    PerotGSoubeyranIRibeiroA. Identification of a recurrent STRN/ALK fusion in thyroid carcinomas. PLoS One2014;9:e87170.

  • 100.

    KellyLMBarilaGLiuP. Identification of the transforming STRN-ALK fusion as a potential therapeutic target in the aggressive forms of thyroid cancer. Proc Natl Acad Sci U S A2014;111:42334238.

    • Search Google Scholar
    • Export Citation
  • 101.

    KunstmanJWJuhlinCCGohG. Characterization of the mutational landscape of anaplastic thyroid cancer via whole-exome sequencing. Hum Mol Genet2015;24:23182329.

    • Search Google Scholar
    • Export Citation
  • 102.

    RosoveMHPeddiPFGlaspyJA. BRAF V600E inhibition in anaplastic thyroid cancer. N Engl J Med2013;368:684685.

  • 103.

    TakanoTItoYHirokawaM. BRAF V600E mutation in anaplastic thyroid carcinomas and their accompanying differentiated carcinomas. Br J Cancer2007;96:15491553.

    • Search Google Scholar
    • Export Citation
All Time Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 277 276 24
PDF Downloads 63 63 9
EPUB Downloads 0 0 0